Continued from Part 2

Product Monographs for Moderna mRNA influenza vaccines

Government of Canada Drug Product Database:
https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html

Click “Search the Drug Product Database” button.

Go to “Search by other criteria”

In the Company field, enter “Moderna”

In all other fields, select “Select All”

Click “Search” button.

The two products at the top are for influenza.

The DIN number for the first one, MCOFLU, is: 02573288

Click on that link.

The page that comes up shows that this product is for both influenza and COVID-19:

Anatomical Therapeutic Chemical (ATC): J07BB55 INFLUENZA AND COVID-19, RNA-BASED VACCINE

Active ingredient group (AIG) number: 0468755001

From footnote:

The AIG number is a 10 digit number that identifies products that have the same active ingredient(s) and ingredient strength(s). The AIG is comprised of three portions:

the first portion (2 digits) identifies the number of active ingredients,
the second portion (5 digits) identifies the unique groups of active ingredients(s),
the last portion (3 digits) identifies the active ingredient group strength. The strength group has a tolerance of ‑2% to +10%.

List of active ingredient(s)
Active ingredient(s) Strength
*INFLUENZA A/H1N1 MRNA, 5?(M7G-5?-PPP-5?-GM) CAP, 3? POLY(A) TAIL 8.3 MCG / 0.32 ML
*INFLUENZA A/H3N2 MRNA, 5?(M7G-5?-PPP-5?-GM) CAP, 3? POLY(A) TAIL 8.3 MCG / 0.32 ML
*INFLUENZA B/VICTORIA MRNA, 5?(M7G-5?-PPP-5?-GM) CAP, 3? POLY(A) TAIL 8.3 MCG / 0.32 ML
*SARSCOV2 S-PROTEIN NTD-RBD SUBDOMAINS MRNA, 5′(M7G-5′-PPP-5′-GM), 3’POLYA 6.7 MCG / 0.32 ML

The product monograph for mCOFLU® is at https://pdf.hres.ca/dpd_pm/00086615.PDF

Next, open the link https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=107514 for the second product, MFLUSIVA by clicking on the DIN link “02573245”

Number of active ingredient(s): 3

Anatomical Therapeutic Chemical (ATC): J07BB05 INFLUENZA, RNA-BASED VACCINES

List of active ingredient(s)
Active ingredient(s) Strength
*INFLUENZA A/H1N1 MRNA, 5?(M7G-5?-PPP-5?-GM) CAP, 3? POLY(A) TAIL 12.5 MCG / 0.38 ML
*INFLUENZA A/H3N2 MRNA, 5?(M7G-5?-PPP-5?-GM) CAP, 3? POLY(A) TAIL 12.5 MCG / 0.38 ML
*INFLUENZA B/VICTORIA MRNA, 5?(M7G-5?-PPP-5?-GM) CAP, 3? POLY(A) TAIL 12.5 MCG / 0.38 ML

Note that this product does not list the COVID (SARSCOV2 S-PROTEIN) ingredient.

The product monograph link for MFLUSIVA opens https://pdf.hres.ca/dpd_pm/00086592.PDF